- Home
- WMPN vs GNLX Comparison
WMPN vs GNLX Comparison
Compare WMPN & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMPN
- GNLX
- Stock Information
- Founded
- WMPN 1870
- GNLX 2001
- Country
- WMPN United States
- GNLX United States
- Employees
- WMPN N/A
- GNLX N/A
- Industry
- WMPN Savings Institutions
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- WMPN Finance
- GNLX Health Care
- Exchange
- WMPN Nasdaq
- GNLX Nasdaq
- Market Cap
- WMPN 104.2M
- GNLX 85.0M
- IPO Year
- WMPN N/A
- GNLX 2023
- Fundamental
- Price
- WMPN $12.55
- GNLX $3.17
- Analyst Decision
- WMPN Buy
- GNLX Strong Buy
- Analyst Count
- WMPN 1
- GNLX 4
- Target Price
- WMPN $14.00
- GNLX $18.25
- AVG Volume (30 Days)
- WMPN 14.4K
- GNLX 80.9K
- Earning Date
- WMPN 01-15-2025
- GNLX 11-14-2024
- Dividend Yield
- WMPN 0.99%
- GNLX N/A
- EPS Growth
- WMPN N/A
- GNLX N/A
- EPS
- WMPN N/A
- GNLX N/A
- Revenue
- WMPN $20,363,000.00
- GNLX $8,000.00
- Revenue This Year
- WMPN N/A
- GNLX N/A
- Revenue Next Year
- WMPN N/A
- GNLX N/A
- P/E Ratio
- WMPN N/A
- GNLX N/A
- Revenue Growth
- WMPN N/A
- GNLX N/A
- 52 Week Low
- WMPN $10.80
- GNLX $1.60
- 52 Week High
- WMPN $13.87
- GNLX $12.12
- Technical
- Relative Strength Index (RSI)
- WMPN 59.49
- GNLX 68.05
- Support Level
- WMPN $11.18
- GNLX $2.25
- Resistance Level
- WMPN $13.08
- GNLX $2.57
- Average True Range (ATR)
- WMPN 0.32
- GNLX 0.25
- MACD
- WMPN 0.12
- GNLX 0.06
- Stochastic Oscillator
- WMPN 72.11
- GNLX 71.31
About WMPN William Penn Bancorporation
William Penn Bancorporation operates as an independent community financial services provider. The bank offers traditional banking and related financial services to individual, business, and government customers. Through its branch and automated teller machine network, the bank offers a full array of commercial and retail financial services, including; the taking of time, savings, and demand deposits; the making of commercial, consumer, and mortgage loans; and the providing of other financial services.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.